Apart from generation of huge amount of intellectual properties, Vipragen will provide its technical and pre-clinical expertise and work exclusively with the American company for the development of the drug and clinical treatment strategies.
The ELEVATE 100 roadshow has traversed the length and breadth of Karnataka in a rigorous hunt to pick the 100 most innovative start-ups and help them turn their ideas into successful businesses. The short-listed startups
Veena Rao, CEO of Vipragen, a startup founded in 2012 in Bangalore, said the drug-discovery environment has seen a surge of small companies. "Biotech companies need a strategic preclinical partner for performing discovery-driven, preclinical testing,"
VIPRAGEN BIOSCIENCES is an integrated Pre-Clinical technology provider Biotech company based at Mysore. We partner and collaborate with biotech, pharma, research or new ventures providing research capabilities in Preclinical Biology, Microbiology, Molecular biology, Cell culture,
In a short time since its inception, Vipragen has achieved global accreditations by CPCSA, AAALAC and is on the verge of achieving GLP accreditation. Vipragen was also one among the 11 biotech start-ups to get
Though India makes up 16% of the world's population and 20% of the world's disease burden, less than 1.4% of global clinical trials are carried out in the country. Of 236,329 ongoing global clinical studies,
In a breakthrough in May 2017, scientists in Bengaluru had found a new molecule that can enhance the efficiency of the autophagy—our body’s own housekeeping mechanism: A process where healthy cells clean up toxic proteins
Vipragen was one among the 100 firms that was picked by the Karnataka state government as part of its ELEVATE programme in 2017 that identified the most innovative startups in the state.
Vipragen is proud to announce that Dr. Chaitra Harsha, Managing Director, Vipragen Biosciences Pvt Ltd has been awarded FLO Women Achiever’s Award 2019 from FICCI.